Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction: Exploring the Dapagliflozin Connection

NCT06510270 is registered in ClinicalTrials.gov with Aswan University as lead sponsor.

NCT NCT06510270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06510270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction: Exploring the Dapagliflozin Connection
Lead sponsor
Aswan University
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2024
Completion date
October 1, 2025
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction